Osimertinib — Dosing in CKD & Dialysis
Osimertinib (Tyrosine Kinase Inhibitor): renal dosing adjustments, dialyzability (Not measurably removed in one hemodialysis patient: osimertinib concentrations measured before, after and without hemodialysis showed that hemodialysis did not affect its pharmacokinetics (Matsunashi 2020, PMID 3148698
Reviewed by Matt · November 16, 2026